Matches in Wikidata for { <http://www.wikidata.org/entity/Q99588682> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q99588682 description "article scientifique publié en 2020" @default.
- Q99588682 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99588682 description "scientific article published on 21 September 2020" @default.
- Q99588682 description "wetenschappelijk artikel" @default.
- Q99588682 description "наукова стаття, опублікована 21 вересня 2020" @default.
- Q99588682 name "CPX-351 - Daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia" @default.
- Q99588682 name "CPX-351 - Daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia" @default.
- Q99588682 type Item @default.
- Q99588682 label "CPX-351 - Daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia" @default.
- Q99588682 label "CPX-351 - Daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia" @default.
- Q99588682 prefLabel "CPX-351 - Daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia" @default.
- Q99588682 prefLabel "CPX-351 - Daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia" @default.
- Q99588682 P1433 Q99588682-A9C9E005-77AE-4E4B-9DA1-E65ACA4F81E4 @default.
- Q99588682 P1476 Q99588682-6CCA5210-0C4A-4446-A8CC-A4909D62B4A4 @default.
- Q99588682 P2093 Q99588682-081DD682-E74E-4782-8742-9C4D992F328C @default.
- Q99588682 P2093 Q99588682-135A2DDA-DF99-4861-8ADE-6890BED44DFF @default.
- Q99588682 P2093 Q99588682-182E65D6-9939-43EF-9256-63CAD84A523C @default.
- Q99588682 P2093 Q99588682-31388DA6-4793-4ACF-ACA4-1E1C97B27F43 @default.
- Q99588682 P2093 Q99588682-345D5BEA-007C-4D2E-8374-6F5DEAF503ED @default.
- Q99588682 P2093 Q99588682-4A1CA7BA-D826-4053-9D5D-AA77D906A26D @default.
- Q99588682 P2093 Q99588682-66FA5E8C-534A-4D14-B1CC-E7FC19477421 @default.
- Q99588682 P2093 Q99588682-DB931687-1C0C-4005-90E1-10895CC9F425 @default.
- Q99588682 P2093 Q99588682-E31450A1-8605-4877-A78D-4CE8E612E0F4 @default.
- Q99588682 P31 Q99588682-1D198585-1A89-4873-AC48-EC16CDBCE261 @default.
- Q99588682 P356 Q99588682-C1BCD0C5-FBB1-4786-BB83-D9CD1FB354C8 @default.
- Q99588682 P577 Q99588682-96D1460D-8AA3-4412-857E-150CFF672638 @default.
- Q99588682 P698 Q99588682-33DE2F2C-B010-442E-AA21-46D78FD3A488 @default.
- Q99588682 P921 Q99588682-725AAE08-AE3C-427E-B0EC-C5C82E62EDEF @default.
- Q99588682 P356 S0026-4806.20.07017-2 @default.
- Q99588682 P698 32955826 @default.
- Q99588682 P1433 Q23091881 @default.
- Q99588682 P1476 "CPX-351 - Daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia" @default.
- Q99588682 P2093 "Alessandro Cafaro" @default.
- Q99588682 P2093 "Andrea Ghelli Luserna Di Rorá" @default.
- Q99588682 P2093 "Carla Masini" @default.
- Q99588682 P2093 "Claudio Cerchione" @default.
- Q99588682 P2093 "Delia Cangini" @default.
- Q99588682 P2093 "Giorgia Simonetti" @default.
- Q99588682 P2093 "Giovanni Martinelli" @default.
- Q99588682 P2093 "Maria Benedetta Giannini" @default.
- Q99588682 P2093 "Paolo Silimbani" @default.
- Q99588682 P31 Q13442814 @default.
- Q99588682 P356 "10.23736/S0026-4806.20.07017-2" @default.
- Q99588682 P577 "2020-09-21T00:00:00Z" @default.
- Q99588682 P698 "32955826" @default.
- Q99588682 P921 Q264118 @default.